Dossier
Glenmark Pharmaceuticals
Coverage of Glenmark Pharmaceuticals in the Nexus archive.
- STAT+: Sandoz to pay $478.5 million to settle price-fixing allegations in long-running battle with states
Sandoz agreed to pay $478.5 million to settle allegations of price-fixing generic drugs, including $400 million over seven years to states and $28.5 million to resellers. The company denied wrongdoing as part of a long-running legal battle with states and resellers over inflated drug prices.
- Have you bought these medications in New York? Find out if you’re entitled to compensation for being overcharged after a recent court order
A $25 million settlement involving Glenmark Pharmaceuticals and other companies was reached after allegations of price-fixing for over 100 generic drugs. Consumers who purchased medications like Prozac, Adderall, and Flonase between 2009 and 2019 may be eligible for compensation.